Investors

Elevar Therapeutics is a fully integrated biopharmaceutical company
dedicated to elevating treatment experiences and outcomes for patients.

VIRTUAL KOL EVENT HELD AUGUST 10, 2023

Discussion on Phase 3 Study of Rivoceranib in Combination with Camrelizumab in Unresectable Hepatocellular Carcinoma (uHCC)

Watch now

ELEVAR CORPORATE PRESENTATION

Sign Up To Receive Investor Notifications